Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Thyroid Neoplasms
×
pembrolizumab
×
30 days
×
Clear all
Filters
3
NCT03360890
2026-03-13
iPRIME
University of Chicago
Phase 2
Active not recruiting
46 enrolled
NCT07419932
2026-02-19
NeoLATC
Fujian Medical University
Recruiting
120 enrolled